Prestige Estates Projects Q4 Profit Surges 10x to 250 Crore Amid Rangebound Stock Performance Australia Shares Dip as SPASX 200 Closes Lower by 039 Prediction Markets Face Mounting Legal Pressure StateFederal Regulatory Clash Intensifies European AI Stocks Surge Over 100 as Investor Frenzy Drives Blockbuster Rally Geopolitical Tensions Rise US Stock Futures and Bond Yields Decline on Reports of Updated Russian Nuclear Doctrine New York Fed Study Reveals Gas Price Surge Disproportionately Impacts LowerIncome Households PowerFleet Inc AIOT Q1 2026 Earnings EPS Surges Past Estimates Revenue Details Unavailable Flutter Entertainment Q1 2026 Earnings EPS Slightly Misses Estimates Amidst Strong Operating Trends Immunovant Q1 2026 Earnings Wider Than Expected Loss Amid No Revenue Revvity Q1 2026 Earnings EPS Surpasses Consensus Stock Slips on Missing Revenue Details PEBO Q1 2026 Earnings Narrow EPS Miss Leads to Modest Stock Decline EZRA Q1 2023 Earnings Record EPS Surges on NonRecurring Gains Revenue Details Lacking Boyd Gaming BYD Shows Resilience with 173 Gain Testing Key Resistance at 8471 US Global Investors Inc GROW Edges Lower Amid Light Trading Support Levels in Focus Hydrofarm HYFM Tests Sub1 Threshold as Bullish Momentum Builds Tillys Inc TLYS Shows Early Signs of Recovery as Shares Bounce from Support Auddia Inc AUUD Slides 688 as Sellers Test Key Support Near 142 DTE Energy Preferred DTW Holds Steady Near Par Yield Appeal and Technical Support in Focus CVRx Inc CVRX Slips 104 as Stock Hovers Near Key Support Zone Keurig Dr Pepper KDP Gains 27 as Beverage Stock Breaks Above Key Moving Averages Reviva Pharmaceuticals Holdings Inc RVPH Holds Steady at 041 as Key Levels Define Trading Range Society Pass SOPA Holds Steady at 008 Amidst Low Volatility Bank OZK Preferred Stock OZKAP Holds Steady Near Support as Trading Activity Remains Subdued Standard Chartered Plans to Cut Over 15 of Corporate Functions Roles Targets Higher Returns by 2028 BOBS Q1 2026 Earnings EPS Surges Past Estimates Shares Dip Despite Strong Beat Protalix BioTherapeutics PLX Gains 345 as Stock Approaches Key Resistance